CD36 and neoplasm: Furthermore, antitumor immunomodulatory effects in tumor-bearing hosts have been demonstrated; a decrease in Tregs and MDSCs and an increase in CD8+ T cell-producing IFN-γ and granzyme B was shown, suggesting that the combination of ICIs and CD36 inhibitors may have synergistic effects [42].